Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
QIFENG
873169
5
LAISAI LASER
871263
CN Stock MarketDetailed Quotes
301520 Anhui Wanbang Pharmaceutical Technology
- 37.39
- -0.65-1.71%
Market Closed May 9 15:00 CST
2.49BMarket Cap36.84P/E (TTM)
38.05High37.35Low6.56KlotVolume38.03Open38.04Pre Close24.64MTurnover2.92%Turnover Ratio29.14P/E (Static)66.67MShares54.1552wk High1.66P/B838.40MFloat Cap33.4552wk Low45.65Limit Up22.42MShs Float89.15Historical High30.43Limit Down1.84%Amplitude33.45Historical Low0.85Dividend TTM37.58Avg Price3.78KlotAsk2.27%Div YieldTTM100Lot Size2.61KlotBid
Anhui Wanbang Pharmaceutical Technology Key Stats
Anhui Wanbang Pharmaceutical Technology Q1 2025 Earnings Date
Currency：CNYApr 22, 2025
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | -- | 71.05M | -- |
-21.20% | |||
| EPS | -- | 0.18 | -- |
-60.00% |
Analyst Rating
May 9, 2025
Anhui Wanbang Pharmaceutical Technology Earnings Estimates
Revenue
EPS
EBIT
No Data
Anhui Wanbang Pharmaceutical Technology Earnings Reports
Read more
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting